PCI Complexity Influences Optimal Duration of DAPT

Share this content:
PCI Complexity Influences Optimal Duration of DAPT
PCI Complexity Influences Optimal Duration of DAPT

MONDAY, Aug. 29, 2016 (HealthDay News) -- The safety of dual antiplatelet therapy (DAPT) duration varies with percutaneous coronary intervention (PCI) complexity, according to research published online Aug. 29 in the Journal of the American College of Cardiology. The research was published to coincide with the annual European Society of Cardiology Congress, held from Aug. 27 to 31 in Rome.

Gennaro Giustino, M.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues pooled data from six randomized controlled trials examining DAPT durations after PCI. Data were included for 9,577 patients for whom procedural variables were available, of whom 17.5 percent underwent complex PCI.

The researchers found that patients who underwent complex PCI had a higher risk of major adverse cardiovascular events (MACE) at a median follow-up of 392 days (adjusted hazard ratio, 1.98; 95 percent confidence interval, 1.50 to 2.60). Significant reductions in MACE were seen for long-term versus short-term DAPT in the complex PCI group (adjusted hazard ratio, 0.56; 95 percent confidence interval, 0.35 to 0.89) versus noncomplex PCI (adjusted hazard ratio, 1.01; 95 percent confidence interval, 0.75 to 1.35). For long-term DAPT, the magnitude of the benefit was progressively greater per increase in procedural complexity. Long-term DAPT was associated with elevated bleeding risk, which was equivalent between the groups.

"Alongside other established clinical risk factors, procedural complexity is an important parameter to take into account in tailoring upfront duration of DAPT," the authors write.

Several authors disclosed financial ties to the pharmaceutical and medical device industries; Medtronic provided the data for the OPTIMIZE trial.

Full Text (subscription or payment may be required)
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

NTproBNP Levels Are Significantly Lower in Blacks

NTproBNP Levels Are Significantly Lower in Blacks

Higher NTproBNP levels linked to increased risk of death; this association did not differ by race

Data May Weigh on Pros/Cons of Expanded Care Optometry

Data May Weigh on Pros/Cons of Expanded Care ...

Majority of residents in Kentucky, Oklahoma, New Mexico live within 30 minutes of ophthalmologist

Gaps Seen Between Hearing Loss, Receipt of Medical Evaluation, Tx

Gaps Seen Between Hearing Loss, Receipt of Medical ...

About 20.6 percent of those with hearing less than excellent/good had visited doctor for hearing issues

is free, fast, and customized just for you!

Already a member?

Sign In Now »